KSE - Delayed Quote KRW

Kolon Corporation (002020.KS)

Compare
22,950.00
+1,750.00
+(8.25%)
At close: 3:30:25 PM GMT+9
Loading Chart for 002020.KS
  • Previous Close 21,200.00
  • Open 22,200.00
  • Bid 22,850.00 x --
  • Ask 22,950.00 x --
  • Day's Range 21,650.00 - 23,000.00
  • 52 Week Range 12,570.00 - 31,000.00
  • Volume 85,478
  • Avg. Volume 154,827
  • Market Cap (intraday) 305.531B
  • Beta (5Y Monthly) 0.89
  • PE Ratio (TTM) --
  • EPS (TTM) --
  • Earnings Date May 14, 2025 - May 19, 2025
  • Forward Dividend & Yield 550.00 (2.58%)
  • Ex-Dividend Date Dec 27, 2024
  • 1y Target Est --

Kolon Corporation engages in market research and management consulting, and intellectual property licensing businesses in South Korea and internationally. The company provides tire cords, airbags, PET spunbond, industrial yarns, chamude, humidity control devices, films, IT chemicals, and petroleum resins, as well as aramid, MEA, PEM, DFR, and CPI products; and golf wear, men's and women's apparel, and accessories. It also trades in steel, natural resources, and chemicals; and constructs buildings, housing, plants, as well as undertakes civil engineering and environmental projects. In addition, the company produces car seat fabrics, modules, and artificial turf; engineering plastics, including PA, PBT, and POM; base and compound resins; and aircraft external fuel tanks, airframe structures, engine vanes, submarine non-pressure hulls, sonar domes, acoustic windows, guided weapon launchers and flame treatment devices, personal bulletproof boards, system bulletproof structures, satellite and satellite projectile structures, combustion tubes, and KGGB products. Further, it provides IT services; supplies hardware and software solutions; manages hotels, condominiums, and golf resorts; develops real estate properties; and operates a shopping mall, a pet theme park, and themed toilets. Additionally, the company offers over-the-counter medicines; TRAMOL sustained relief, a painkiller and anti-inflammatory; active pharmaceutical ingredients; and Tissuegene and other biopharmaceuticals, as well as operates drugstores under the W-Store name. It also operates Sweet Meal, a café that offers choux, coffee, cheesecakes, and beverages; sells antimicrobial products; and provides automobile sales and repair services. Kolon Corporation was founded in 1957 and is headquartered in Gwacheon-si, South Korea.

www.kolon.com

--

Full Time Employees

December 31

Fiscal Year Ends

Recent News: 002020.KS

View More

Performance Overview: 002020.KS

Trailing total returns as of 4/10/2025, which may include dividends or other distributions. Benchmark is KOSPI Composite Index (^KS11) .

YTD Return

002020.KS
63.58%
KOSPI Composite Index (^KS11)
1.90%

1-Year Return

002020.KS
44.17%
KOSPI Composite Index (^KS11)
9.61%

3-Year Return

002020.KS
12.13%
KOSPI Composite Index (^KS11)
9.46%

5-Year Return

002020.KS
88.30%
KOSPI Composite Index (^KS11)
31.41%

Compare To: 002020.KS

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 002020.KS

View More

Valuation Measures

Annual
As of 4/9/2025
  • Market Cap

    282.23B

  • Enterprise Value

    2.43T

  • Trailing P/E

    1.68

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.05

  • Price/Book (mrq)

    0.18

  • Enterprise Value/Revenue

    0.40

  • Enterprise Value/EBITDA

    4.90

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    2.83%

  • Return on Assets (ttm)

    -0.90%

  • Return on Equity (ttm)

    8.80%

  • Revenue (ttm)

    6.03T

  • Net Income Avi to Common (ttm)

    173.67B

  • Diluted EPS (ttm)

    --

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    492.72B

  • Total Debt/Equity (mrq)

    113.59%

  • Levered Free Cash Flow (ttm)

    -347.25B

Research Analysis: 002020.KS

View More

Company Insights: 002020.KS

Research Reports: 002020.KS

View More

People Also Watch

Waiting for permission
Allow microphone access to enable voice search

Try again.